Inventor · disambiguated record
Donald Bierer
Also filed as: BIERER DONALD · BIERER DONALD E
35 granted patents·20 pending applications·285 citations·filing 1993–2023
97Inventor score
Files withSHAMAN PHARMACEUTICALS INC14ADVERIO PHARMA GMBH8BAYER PHARMACEUTICALS CORP7BAYER AG5Bayer Pharma AG5
Top patents by PatentIndex Score
55 records- 0197US8420656B2Substituted 5-fluoro-1H-pyrazolopyridines and their useFOLLMANN MARKUS·Filed 2011·Granted Apr 16, 2013·62 cites·7 claims
- 0296US9993476B2Substituted 5-flouro-1H-pyrazolopyridines and their useADVERIO PHARMA GMBH·Filed 2016·Granted Jun 12, 2018·16 cites·13 claims
- 0396US8921377B2Substituted 5-fluoro-1H-pyrazolopyridines and their useBAYER IP GMBH·Filed 2013·Granted Dec 30, 2014·30 cites·12 claims
- 0495US11439642B2Substituted 5-fluoro-1H-pyrazolopyridines and their useADVERIO PHARMA GMBH·Filed 2020·Granted Sep 13, 2022·3 cites·66 claims
- 0593US9604948B2Process for preparing substituted 5-fluoro-1H-pyrazolopyridinesADVERIO PHARMA GMBH·Filed 2015·Granted Mar 28, 2017·5 cites·8 claims
- 0692US9266885B2Substituted 5-fluoro-1H-pyrazolopyridines and their useBAYER IP GMBH·Filed 2014·Granted Feb 23, 2016·11 cites·12 claims
- 0789US10736896B2Substituted 5-fluoro-1H-pyrazolopyridines and their useADVERIO PHARMA GMBH·Filed 2018·Granted Aug 11, 2020·2 cites·7 claims
- 0888US7563791B2Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisBAYER PHARMACEUTICALS CORP·Filed 2005·Granted Jul 21, 2009·14 cites·8 claims
- 0987US6849638B24-amino-5,6-substituted thiopheno [2,3-d] pyrimidines, pharmaceutical compositions containing the same, and their use in the treatment or prevention of pde7b-mediated diseases and conditionsBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Feb 1, 2005·36 cites·12 claims
- 1086US12064429B2Substituted 5-fluoro-1H-pyrazolopyridines and their useADVERIO PHARMA GMBH·Filed 2022·Granted Aug 20, 2024·0 cites·18 claims
- 1185US7678804B2Pyrimidine derivatives for treatment of hyperproliferative disordersBAYER HEALTHCARE LLC·Filed 2005·Granted Mar 16, 2010·4 cites·11 claims
- 1283US10905667B2Orally administrable modified-release pharmaceutical dosage formBayer Pharma AG·Filed 2018·Granted Feb 2, 2021·2 cites·25 claims
- 1381US5741926AAniline derivatives having antihyperglycemic activitySHAMAN PHARMACEUTICALS INC·Filed 1997·Granted Apr 21, 1998·28 cites·4 claims
- 1480US10633356B2Hydrates of substituted 5-fluoro-1H-pyrazolopyridinesADVERIO PHARMA GMBH·Filed 2019·Granted Apr 28, 2020·0 cites·12 claims
- 1576US5629319AHypoglycemic agent from cryptolepisSHAMAN PHARMACEUTICALS INC·Filed 1995·Granted May 13, 1997·18 cites·11 claims
- 1671US12503491B2MASP inhibitory compounds and uses thereofBAYER AG·Filed 2023·Granted Dec 23, 2025·0 cites·8 claims
- 1770US7582645B2Pyrimidine derivatives for treatment of hyperproliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Sep 1, 2009·4 cites·10 claims
- 1869US10364229B2Crystalline substituted 5-fluoro-1H-pyrazolopyridines and process for preparingADVERIO PHARMA GMBH·Filed 2017·Granted Jul 30, 2019·0 cites·3 claims
- 1968US2022257547A1Orally administrable modified-release pharmaceutical dosage formBayer Pharma AG·Filed 2022·Application pending·0 cites
- 2067US2010075967A1Pyrimidine derivatives for treatment of hyperproliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2009·Application pending·0 cites
- 2166US11344519B2Orally administrable modified-release pharmaceutical dosage formBayer Pharma AG·Filed 2020·Granted May 31, 2022·0 cites·2 claims
- 2262US11667675B2MASP inhibitory compounds and uses thereofBAYER AG·Filed 2020·Granted Jun 6, 2023·0 cites·3 claims
- 2362US8338595B2Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisDIXON JULIE A·Filed 2009·Granted Dec 25, 2012·0 cites·8 claims
- 2460US5681958ACryptolepine analogs with hypoglycemic activitySHAMAN PHARMACEUTICALS INC·Filed 1995·Granted Oct 28, 1997·7 cites·13 claims
- 2560US2016129004A1Substituted 5-fluoro-1h-pyrazolopyridines and their useADVERIO PHARMA GMBH·Filed 2016·Application pending·0 cites
- 2655US5681829AClass of phosphocholine derivatives having antifungal activitySHAMAN PHARMACEUTICALS INC·Filed 1993·Granted Oct 28, 1997·15 cites·16 claims
- 2753US2013225809A1Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisBAYER HEALTHCARE LLC·Filed 2012·Application pending·0 cites
- 2852US2024010684A1Masp inhibitory compounds and uses thereofBAYER AG·Filed 2021·Application pending·0 cites
- 2950US5583235APreparation of symmetrical and unsymmetrical 3,6-disubstituted-1,2-dithiins having antifungal activitySHAMAN PHARMACEUTICALS INC·Filed 1994·Granted Dec 10, 1996·5 cites·16 claims
- 3049US5648354A1,2-dithiins having antifungal activitySHAMAN PHARMACEUTICALS INC·Filed 1995·Granted Jul 15, 1997·4 cites·9 claims
- 3148US2023072421A1Targeted radiopharmaceuticals for the diagnosis and treatment of prostate cancerBAYER AS·Filed 2020·Application pending·0 cites
- 3245US2011195110A1Urea compounds useful in the treatment of cancerSMITH ROGER·Filed 2006·Application pending·0 cites
- 3344US9586958B2Prodrug derivatives of substituted triazolopyridinesBayer Pharma AG·Filed 2014·Granted Mar 7, 2017·0 cites·14 claims
- 3443US2011098301A1Pyrimidine Derivatives for Treatment of Hyperproliferative DisordersBAYER HEALTHCARE LLC·Filed 2006·Application pending·0 cites
- 3543US2009258888A1Pyrimidine DerivativesBAYER PHARMACEUTICALS CORP·Filed 2006·Application pending·0 cites
- 3643US2009286785A1Pyrimidine DerivativesBAYER PHARMACEUTICALS CORP·Filed 2006·Application pending·0 cites
- 3743US2022387608A1Adrenomedullin-analogues for long-term stabilization and their useBAYER AG·Filed 2020·Application pending·0 cites
- 3842US2008293696A12-Aminoarylcarboxamides Useful as Cancer Chemotherapeutic AgentsBAYER PHARMACEUTICALS CORP·Filed 2005·Application pending·0 cites
- 3941US5925647AMethods for use of cryptolepine analogs with hypoglycemic activitySHAMAN PHARMACEUTICALS INC·Filed 1997·Granted Jul 20, 1999·5 cites·6 claims
- 4040US9422263B2Fluoro-substituted 3,5-dicyano-4-(1H-indazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine derivatives and methods of use thereofMICHELS MARTIN·Filed 2010·Granted Aug 23, 2016·0 cites·10 claims
- 4140US5811568AProcess for the preparation of mono- and bis(phosphocholine) derivatives which have antifungal activitySHAMAN PHARMACEUTICALS INC·Filed 1994·Granted Sep 22, 1998·7 cites·15 claims
- 4240US5628999AHypoglycemic agent from cryptolepisSHAMAN PHARMACEUTICALS INC·Filed 1995·Granted May 13, 1997·4 cites·2 claims
- 4340US2004198773A1Substituted 3-pyridyl oxazoles as c17,20 lyase inhibitorsFiled 2002·Application pending·0 cites
- 4440US2004209924A1Substituted 3-pyridyl imidazoles as c17,20 lyase inhibitorsFiled 2002·Application pending·0 cites
- 4540US2004236110A1Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitorsFiled 2002·Application pending·0 cites
- 4640US2020237648A1Orally administrable modified-released pharmaceutical dosage formBAYER AG·Filed 2019·Application pending·0 cites
- 4738US2019297887A1Bicyclic compounds as pesticidesBAYER CROPSCIENCE AG·Filed 2017·Application pending·0 cites
- 4837US2004267017A13-pyridyl or 4-isoquinolinyl thiazoles as c17, 20 lyase inhibitorsFiled 2002·Application pending·0 cites
- 4936US2013252890A16,7-dihydro-5h-benzo[7]annulene derivatives, process for preparation thereof, pharmaceutical preparations comprising them, and the use thereof for production of medicamentsWINTERMANTEL TIM·Filed 2011·Application pending·0 cites
- 5035US5580897A1,2-dithiins having antifungal activitySHAMAN PHARMACEUTICALS INC·Filed 1995·Granted Dec 3, 1996·1 cites·28 claims
Showing the top 50 of 55 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →